Get the Stockscreener App
19.09
2.31%
-0.4325
Sanara Medtech Inc stock is traded at $19.09, with a volume of 77,903.
It is down -2.31% in the last 24 hours and down -20.43% over the past month.
Sanara MedTech Inc is a medical technology company focused on developing and commercializing transformative technologies to improve clinical outcomes and reduce healthcare expenditures in the chronic and surgical wound and skincare markets. Its portfolio of products and services allows it to deliver comprehensive wound and skincare solutions for patients in all care settings, including acute and post-acute. Its surgical wound care products are CellerateRX Surgical Activated Collagen. Its chronic wound care products are BIAKOS Skin and Wound Cleanser, and BIAKOS Skin and Wound Gel.
See More
Previous Close:
$19.52
Open:
$19.67
24h Volume:
77,903
Relative Volume:
1.35
Market Cap:
$170.54M
Revenue:
$64.99M
Net Income/Loss:
$-4.30M
P/E Ratio:
-36.71
EPS:
-0.52
Net Cash Flow:
$-3.51M
1W Performance:
-4.84%
1M Performance:
-20.43%
6M Performance:
-30.58%
1Y Performance:
-44.74%
1-Day Range:
$18.99
$19.84
1-Week Range:
$18.99
$20.53
52-Week Range:
$18.90
$36.31
Sanara Medtech Inc Stock (SMTI) Company Profile
Name
Sanara Medtech Inc
Sector
Industry
Phone
817-529-2300
Address
1200 SUMMIT AVE, FORT WORTH
Compare SMTI vs ISRG, BDX, ALC, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
SMTI
Sanara Medtech Inc
|
19.09 | 174.42M | 64.99M | -4.30M | -3.51M | -0.52 |
|
ISRG
Intuitive Surgical Inc
|
479.82 | 176.19B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
178.38 | 51.41B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
78.61 | 39.00B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
43.86 | 37.48B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
246.69 | 37.82B | 5.40B | 1.49B | 1.78B | 10.12 |
Sanara Medtech Inc Stock (SMTI) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-26-25 | Reiterated | H.C. Wainwright | Buy |
| Dec-23-24 | Initiated | H.C. Wainwright | Buy |
| May-20-22 | Resumed | Cantor Fitzgerald | Overweight |
| Jun-30-21 | Initiated | Cantor Fitzgerald | Overweight |
Sanara Medtech Inc Stock (SMTI) Latest News
What margin trends mean for Sanara MedTech Inc. stockTrade Entry Report & Weekly Stock Performance Updates - mfd.ru
(SMTI) Movement as an Input in Quant Signal Sets - Stock Traders Daily
Sanara MedTech’s Stock Under the Microscope: Niche Wound-Care Player Tests Investor Patience - AD HOC NEWS
Stop Loss: Is FNGS in a consolidation phasePortfolio Risk Report & Free Community Consensus Stock Picks - baoquankhu1.vn
HC Wainwright Predicts Weaker Earnings for Sanara MedTech - MarketBeat
Analysts Issue Forecasts for Sanara MedTech FY2025 Earnings - Defense World
Sanara MedTech FY2025 EPS Forecast Boosted by HC Wainwright - MarketBeat
Sanara MedTech (NASDAQ:SMTI) Receives “Buy” Rating from HC Wainwright - Defense World
SMTI Latest Analyst Rating Update: HC Wainwright & Co. Reiterates Buy | SMTI Stock News - GuruFocus
HC Wainwright Reiterates Buy Rating for Sanara MedTech (NASDAQ:SMTI) - MarketBeat
Liquidity Mapping Around (SMTI) Price Events - Stock Traders Daily
Can Sanara MedTech Inc. stock outperform in a bear marketJuly 2025 Outlook & Capital Efficiency Focused Strategies - mfd.ru
Sanara MedTech expects 19% revenue growth for 2025, issues 2026 guidance - Investing.com Nigeria
Sanara MedTech reports Q4 preliminary net revenue $27.2M-$27.7M - TipRanks
SMTI Projects Revenue Growth for Q4 and Secures New Contract - GuruFocus
Sanara MedTech Reports Preliminary Financial Results for 2025 and Issues 2026 Guidance - Quiver Quantitative
Sanara MedTech Inc. Reports Unaudited Preliminary Financial Results for the Fourth Quarter and Full Year 2025; Introduces Full Year 2026 Financial Guidance - The Manila Times
Sanara MedTech Reports Unaudited Preliminary Financial Results For The Fourth Quarter And Full Year 2025 Introduces Full Year 2026 Financial Guidance - TradingView
Sanara MedTech Inc. Reports Unaudited Preliminary Financial - GlobeNewswire
Sanara MedTech Inc. (SMTI) Investor Outlook: Strong Buy Ratings Suggest 75% Upside Potential - DirectorsTalk Interviews
Sanara MedTech (NASDAQ:SMTI) Downgraded by Zacks Research to "Hold" - MarketBeat
Is Sanara MedTech Inc. stock a top performer YTDJuly 2025 Macro Moves & Growth Oriented Trade Recommendations - Bollywood Helpline
Aug Levels: Can Sanara MedTech Inc stock outperform in a bear marketLong Setup & Short-Term Trading Opportunity Alerts - baoquankhu1.vn
Sanara MedTech (SMTI) Receives Updated Analyst Rating and Price Target | SMTI Stock News - GuruFocus
Why (SMTI) Price Action Is Critical for Tactical Trading - Stock Traders Daily
Published on: 2026-01-14 01:26:57 - Bộ Nội Vụ
History Review: Can Sanara MedTech Inc deliver consistent dividends2025 Performance Recap & Reliable Breakout Forecasts - baoquankhu1.vn
Will Sanara MedTech Inc. stock recover faster than peers2025 Winners & Losers & Free Technical Pattern Based Buy Signals - ulpravda.ru
Why Sanara MedTech Inc. stock is trending among retail tradersJuly 2025 Volume & Long-Term Safe Investment Plans - Улправда
How Sanara MedTech Inc. stock responds to policy changesJuly 2025 Snapshot & Advanced Swing Trade Entry Alerts - ulpravda.ru
Why Sanara MedTech Inc. stock is favored by top institutionsWeekly Gains Report & Growth Focused Entry Reports - ulpravda.ru
Is Sanara MedTech Inc. stock a safe buy before earningsWeekly Earnings Recap & Safe Entry Zone Tips - Улправда
How Sanara MedTech Inc. stock reacts to Fed rate cutsJuly 2025 Decliners & Weekly High Return Forecasts - Улправда
Sanara MedTech stock rises after securing Vizient contract for BIASURGE By Investing.com - Investing.com Australia
Sanara MedTech’s BIASURGE receives Vizient innovative technology contract By Investing.com - Investing.com Nigeria
Sanara MedTech (SMTI) Secures Innovative Technology Contract for Biasurge - GuruFocus
Sanara MedTech stock rises after securing Vizient contract for BIASURGE - Investing.com
Sanara MedTech’s BIASURGE receives Vizient innovative technology contract - Investing.com
Sanara MedTech Inc. Receives Innovative Technology Contract from Vizient for BIASURGE® Advanced Surgical Solution - The Manila Times
Sanara MedTech (SMTI) Upgraded to Strong Buy: Here's What You Should Know - Yahoo Finance
Sanara MedTech (NASDAQ:SMTI) Stock Price Up 2% – Here’s Why - Defense World
Sanara MedTech (NASDAQ:SMTI) Stock Price Up 2%Here's Why - MarketBeat
What analysts say about Sanara MedTech Inc stockMACD Histogram Signals & Capitalize On Momentum - earlytimes.in
Understanding Momentum Shifts in (SMTI) - Stock Traders Daily
Precision Trading with Sanara Medtech Inc. (SMTI) Risk Zones - Stock Traders Daily
Can Sanara MedTech Stock Recover If Markets Fall? - Trefis
How Sanara MedTech Inc. stock performs in high volatility markets2025 Year in Review & Verified Technical Signals - Улправда
Sanara MedTech Earnings Notes - Trefis
Aug Technicals: Is Sanara MedTech Inc. stock a safe buy before earningsEarnings Beat & Free Real-Time Volume Trigger Notifications - DonanımHaber
Bronstein, Gewirtz & Grossman, LLC Announces an Investigation Against Sanara MedTech, Inc. (SMTI) and Encourages Investors to Learn More About the Investigation - ACCESS Newswire
Sanara Medtech Inc Stock (SMTI) Financials Data
Revenue
Net Income
Cash Flow
EPS
5.49%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):